In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Pfizer Inc. is one of them.

According to DataM Intelligence, "The RNA-Based Therapies Market Size, valued at USD 90.56 billion in 2024, is projected to ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

Discover the latest on Arbutus Biopharma’s patent litigation strategy and investment risks. Learn if ABUS is a speculative ...

On Friday, a CDC advisory panel unanimously recommended limiting the Covid shot to people 65 and older or those with ...

Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

Kennedy says he wants to restore trust in vaccines. His hand-picked ACIP panel raised many doubts, and outside experts were ...

CDC staff presented data showing that hospitalization rates for Covid are highest for adults 75 and older, followed by babies ...

World-renowned RNA biology expert Dr. Jeff Coller will help guide NTx’s next-generation therapeutic platforms on its ...

Last month, the Department of Health and Human Services (HHS) cancelled $500 million in funding for mRNA vaccine research and ...